PFC
ANIP icon

Phocas Financial Corp’s ANI Pharmaceuticals ANIP Stock Holding History

Phocas Financial Corp’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-75,213
Closed -$4.37M – 163
2023
Q3 		$4.37M Sell
75,213
-72
-0.1% -$4.16K 0.64% 71
2023
Q2 		$4.05M Sell
75,285
-419
-0.6% -$18.6K 0.55% 79
2023
Q1 		$3.01M Buy
+75,704
New +$3.19M 0.43% 97
2020
Q1 		– Sell
-101,567
Closed -$6.26M – 187
2019
Q4 		$6.26M Sell
101,567
-25,633
-20% -$1.7M 0.75% 56
2019
Q3 		$9.27M Sell
127,200
-191
-0.1% -$14.3K 0.99% 29
2019
Q2 		$10.5M Sell
127,391
-13,586
-10% -$966K 1.12% 24
2019
Q1 		$9.95M Buy
140,977
+11,501
+9% +$677K 1% 35
2018
Q4 		$5.83M Buy
129,476
+32,671
+34% +$1.71M 0.65% 66
2018
Q3 		$5.47M Buy
96,805
+55,064
+132% +$3.37M 0.48% 93
2018
Q2 		$2.79M Buy
+41,741
New +$2.61M 0.24% 119

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Phocas Financial Corp's ANIP Position: Q4 2023 in Review

Phocas Financial Corp sold out of ANI Pharmaceuticals (ANIP) in Q4 2023, closing a stake of 75,213 shares — an estimated $4.37M sold.

Phocas Financial Corp first reported a position in ANIP in Q2 2018 and held it in 10 quarters. The position peaked at $10.5M in Q2 2019. 181 funds tracked by Wall St. Rank hold ANIP as of Q4 2023.

  • Phocas Financial Corp reported no remaining ANI Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Phocas Financial Corp sold 75,213 ANI Pharmaceuticals shares in Q4 2023, an estimated $4.37M.
  • Phocas Financial Corp first reported a position in ANI Pharmaceuticals in Q2 2018 and held it in 10 quarters.
  • Phocas Financial Corp's ANI Pharmaceuticals position peaked at $10.5M in Q2 2019.
  • 181 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2023.

Based on Phocas Financial Corp's 13F filing for Q4 2023, filed 30 Jan 2024.